NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: A HuGE review

Genetics in Medicine

Volumn 8, Issue 2, 2006, Pages 63-75

  Franceschini, Nora ^a   North, Kari E ^a   Kopp, Jeffrey B ^b   Mckenzie, Louise ^c   Winkler, Cheryl ^c  

^a IL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

FSGS; Nephrotic syndrome; NPHS2; Podocin; Prevalence

Indexed keywords

ARGININE; GLUTAMINE; PODOCIN; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

AFRICA; ALBUMIN BLOOD LEVEL; CASE CONTROL STUDY; EDEMA; EUROPE; FOCAL GLOMERULOSCLEROSIS; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MUTATOR GENE; NEPHROTIC SYNDROME; NPHS2 GENE; POPULATION GENETICS; POPULATION RISK; PROTEINURIA; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; AMINO ACID SUBSTITUTION; ETHNIC GROUP; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PODOCYTE;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; GENE FREQUENCY; GENOTYPE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEPHROTIC SYNDROME; PHENOTYPE; PODOCYTES; POLYMORPHISM, GENETIC;

EID: 33645403446     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gim.0000200947.09626.1c     Document Type: Review

References (40)

1. Fuchshuber A, Jean G, Gribouval O, Gubler MC, et al. Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 1995;4:2155-2158.
2. Boute N, Gribouval O, Roselli S, Benessy F, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000;24:349-354.
3. Tsukaguchi H, Sudhakar A, Le TC , Nguyen T, et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 2002;110:1659-1666.
4. Stewart GW. Stomatin. Int J Biochem Cell Biol 1997;29:271-274.
5. Horinouchi I, Nakazato H, Kawano T, Iyama K, et al. In situ evaluation of podocin in normal and glomerular diseases. Kidney Int 2003;64:2092-2099.
6. Huber TB, Reinhardt C, Simons M, Petraschka D, et al. Direct binding of cholesterol and targeting of nephrin to lipid rafts are disrupted in disease causing podocin mutations. J Am Soc Nephrol 2004;15:33A.
7. Roselli S, Gribouval O, Boute N, Sich M, et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 2002;160:131-139.
8. Schwarz K, Simons M, Reiser J, Saleem MA, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001;108:1621-1629.
9. Huber TB, Simons M, Hartleben B, Sernetz L, et al. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet 2003;12:3397-3405.
10. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575-582.
11. Zhang SY, Marlier A, Gribouval O, Gilbert T, et al. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation. Kidney Int 2004;66:945-954.
12. Koziell A, Grech V, Hussain S, Lee G, et al. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional interrelationship in glomerular filtration. Hum Mol Genet 2002;11:379-388.
13. Weber S, Gribouval O, Esquivel EL, Moriniere V, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low posttransplant recurrence. Kidney Int 2004;66:571-579.
14. Roselli S, Heidet L, Sich M, Henger A, et al. Early glomerular filtration detect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004;24:550-560.
15. Moore D, McCabe G. Introduction to the practice of statistics. 3rd ed. New York: WH Freedman and Company, 1998.
16. Maruyama K, Iijima K, Ikeda M, Kitamura A, et al. NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children. Pediatr Nephrol 2003;18:412-416.
17. Pereira AC, Pereira AB, Mota GF, Cunha RS, et al. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004;65:1026-1030.
18. Dusel JA, Burdon KP, Hicks PJ, Hawkins GA, et al. Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int 2005;68:256-262.
19. Wu MC, Wu JY, Lee CC, Tsai CH, et al. A novel polymorphism (c288C>T) of the NPHS2 gene identified in a Taiwan Chinese family. Hum Mutat 2001;17:81-82.
20. Wu MC, Wu JY, Lee CC, Tsai CH, et al. Two novel polymorphisms (c954T>C and c1038A>G) in exon8 of NPHS2 gene identified in Taiwan Chinese. Hum Mutat 2001;17:237.
21. Karle SM, Uetz B, Ronner V, Glaser L, et al. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002;13:388-393.
22. Caridi G, Bertelli R, Carrea A, DiDuca M, et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 2001;12:2742-2746.
23. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney International 1994;46:1223-1241.
24. Agarwal SK, Dash SC, Tiwari SC, Bhuyan UN, et al. Idiopathic adult focal segmental glomerulosclerosis: a clinicopathological study and response to steroid. Nephron 1993;63:168-171.
25. Ponticelli C, Villa M, Banfi G, Cesana B, et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? American Journal of Kidney Diseases 1999;34:618-625.
26. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM, et al. Focal Segmental Glomerular Sclerosis in Adults: Presentation, Course and Response to treatment. American Journal of Kidney Diseases 1995;25:534-542.
27. Kopp JB, Winkler C . HIV-associated nephropathy in African Americans. Kidney Int Suppl 2003;:S43-S49.
28. Freedman BI, Soucie JM, Stone SM, Pegram S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 1999;34:254-258.
29. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004;44:815-825.
30. Korbet SM. Clinical picture and outcome of primary focal glomeruosclerosis. Nephrol Dial Transplant 1999;14:68-73.
31. Chitalia VC, Wells JE, Robson RA, Searle M, et al. Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney International 1999;56:2236-2242.
32. Ingulli E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pedriatic Nephrology 1991;5: 393-397.
33. Caridi G, Bertelli R, Di Duca M, Dagnino M, et al. Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 2003;14:1278-1286.
34. Aucella F, De Bonis P, Gatta G, Muscarella LA, et al. Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Nephron Clin Pract 2005;99:C31-C36.
35. Ruf RG, Lichtenberger A, Karle SM, Haas JP, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004;15:722-732.
36. Schultheiss M, Ruf RG, Mucha BE, Wiggins R, et al. No evidence for genotype/phenotype correlation in NPHS1 and NPHS2 mutations. Pediatr Nephrol 2004;19:1340-1348.
37. Niaudet P. Podocin and nephrotic syndrome: implications for the clinician. J Am Soc Nephrol 2004;15:832-834.
38. Caridi G, Bertelli R, Scolari F, Sanna-Cherchi S, et al. Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 2003;64:365.
39. Yu Z, Ding J, Huang J, Yao Y, et al. Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant 2005;20(5):902-908.
40. Frishberg Y, Rinat C, Megged O, Shapira E, et al. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol 2002;13(2):400-405.